Literature DB >> 12747466

Expression of alphav integrin family in gastric carcinomas: increased alphavbeta6 is associated with lymph node metastasis.

Atsuhiro Kawashima1, Shuzo Tsugawa, Asami Boku, Masako Kobayashi, Toshinari Minamoto, Isao Nakanishi, Yoshio Oda.   

Abstract

To investigate the alterations as to integrin expression in human gastric carcinomas, we analyzed the alphav subunit and 5 types of beta subunits using reverse transcription-polymerase chain reaction (RT-PCR) and competitive RT-PCR. The incidence of alphav, beta6 and beta8 expression was significantly higher in carcinoma tissues than in non-neoplastic gastric mucosal tissues (NGMTs). Out of 18 carcinoma cases with coexpression of alphav and beta6 subunits, which was demonstrated by RT-PCR, 17 cases (94%) showed lymph node metastasis (p = 0.0033). This tendency was confirmed by immunohistochemistry; most cases (23/28, 82%) in which alphavbeta6 integrin was immunohistochemically detected showed lymph node metastasis (p = 0.0193). RT-PCR and immunohistochemical studies showed that gastric carcinoma tissues expressed beta5 subunit in all cases. Furthermore, in a quantitative analysis using competitive RT-PCR, the mean level of beta5 expression was approximately 140 times higher in gastric carcinomas than in NGMTs. Most gastric carcinoma cases (27/38, 71%) were immunohistochemically positive for beta8 subunit. These findings suggest that some members of the alphav integrin family (alphavbeta5, alphavbeta6, alphavbeta8) are up-regulated, and that alphavbeta6 integrin may be involved in the lymphatic metastasis of gastric carcinomas.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12747466     DOI: 10.1078/0344-0338-00355

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  26 in total

1.  Dual inhibition of αV integrins and Src kinase activity as a combination therapy strategy for colorectal cancer.

Authors:  Jingquan Jia; Alex Starodub; Ian Cushman; Yingmiao Liu; Deborah J Marshall; Herbert I Hurwitz; Andrew B Nixon
Journal:  Anticancer Drugs       Date:  2013-03       Impact factor: 2.248

Review 2.  Molecular imaging of integrin αvβ6 expression in living subjects.

Authors:  Hao Liu; Yue Wu; Fan Wang; Zhaofei Liu
Journal:  Am J Nucl Med Mol Imaging       Date:  2014-06-07

3.  Synthesis and biological evaluation of a peptide-paclitaxel conjugate which targets the integrin αvβ₆.

Authors:  Shunzi Li; Bethany Powell Gray; Michael J McGuire; Kathlynn C Brown
Journal:  Bioorg Med Chem       Date:  2011-08-04       Impact factor: 3.641

4.  MRI-visible micellar nanomedicine for targeted drug delivery to lung cancer cells.

Authors:  Jagadeesh Setti Guthi; Su-Geun Yang; Gang Huang; Shunzi Li; Chalermchai Khemtong; Chase W Kessinger; Michael Peyton; John D Minna; Kathlynn C Brown; Jinming Gao
Journal:  Mol Pharm       Date:  2010-02-01       Impact factor: 4.939

5.  CNTO 95, a fully human anti alphav integrin antibody, inhibits cell signaling, migration, invasion, and spontaneous metastasis of human breast cancer cells.

Authors:  Qiming Chen; Carol D Manning; Hillary Millar; Francis L McCabe; Catherine Ferrante; Celia Sharp; Lillian Shahied-Arruda; Parul Doshi; Marian T Nakada; G Mark Anderson
Journal:  Clin Exp Metastasis       Date:  2007-12-05       Impact factor: 5.150

6.  Surface Functionalization of Chemically Reduced Graphene Oxide for Targeted Photodynamic Therapy.

Authors:  Peng Huang; Shouju Wang; Xiansong Wang; Guangxia Shen; Jing Lin; Zhe Wang; Shouwu Guo; Daxiang Cui; Min Yang; Xiaoyuan Chen
Journal:  J Biomed Nanotechnol       Date:  2015-01       Impact factor: 4.099

7.  Synthesis and characterization of a high-affinity {alpha}v{beta}6-specific ligand for in vitro and in vivo applications.

Authors:  Shunzi Li; Michael J McGuire; Mai Lin; Ying-Horng Liu; Tsukasa Oyama; Xiankai Sun; Kathlynn C Brown
Journal:  Mol Cancer Ther       Date:  2009-05-12       Impact factor: 6.261

8.  Application of a novel method of double APAAP staining with subsequent quantitative image analysis to the examination of integrin expression in undifferentiated-type gastric carcinomas.

Authors:  Natalia Yanchenko; Hiroyuki Sugihara; Takanori Hattori
Journal:  J Histochem Cytochem       Date:  2009-08-17       Impact factor: 2.479

9.  Peptide-targeted polyglutamic acid doxorubicin conjugates for the treatment of alpha(v)beta(6)-positive cancers.

Authors:  Huili Guan; Michael J McGuire; Shunzi Li; Kathlynn C Brown
Journal:  Bioconjug Chem       Date:  2008-08-19       Impact factor: 4.774

10.  From phage display to nanoparticle delivery: functionalizing liposomes with multivalent peptides improves targeting to a cancer biomarker.

Authors:  Bethany Powell Gray; Shunzi Li; Kathlynn C Brown
Journal:  Bioconjug Chem       Date:  2013-01-07       Impact factor: 4.774

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.